Harald Prüss

1 Patent

• US126178352026

  Chimeric Autoantibody Receptor (CAAR) That Binds Autoantibodies Targeting the Central Nervous System in Neurological Autoimmune Disease

  Max-delbrück-centrum Für Molekulare Medizin In Der Helmholtz-gemeinschaft

  0 cites